M Bouvier

958 total citations
29 papers, 688 citations indexed

About

M Bouvier is a scholar working on Hematology, Rheumatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M Bouvier has authored 29 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 10 papers in Rheumatology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M Bouvier's work include Hematopoietic Stem Cell Transplantation (9 papers), Acute Lymphoblastic Leukemia research (5 papers) and Clinical Nutrition and Gastroenterology (4 papers). M Bouvier is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Acute Lymphoblastic Leukemia research (5 papers) and Clinical Nutrition and Gastroenterology (4 papers). M Bouvier collaborates with scholars based in United States, France and Italy. M Bouvier's co-authors include George B. McDonald, Ted Gooley, Ami Batchelder, H. Gary Schoch, Claudio Anasetti, Song Ren, John T. Slattery, Thomas F. Kalhorn, David M. Hockenbery and Allen Farrand and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

M Bouvier

27 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Bouvier United States 11 427 175 157 143 126 29 688
Kyu Bo Lee South Korea 15 348 0.8× 229 1.3× 121 0.8× 228 1.6× 83 0.7× 38 681
Ted Gooley United States 9 419 1.0× 123 0.7× 56 0.4× 111 0.8× 94 0.7× 15 614
Á Figuera Spain 17 545 1.3× 215 1.2× 59 0.4× 92 0.6× 157 1.2× 43 795
Ami Batchelder United States 11 418 1.0× 130 0.7× 113 0.7× 47 0.3× 196 1.6× 13 692
E. Winton United States 13 403 0.9× 148 0.8× 40 0.3× 77 0.5× 134 1.1× 23 608
Lynne Kaminer United States 14 219 0.5× 170 1.0× 189 1.2× 83 0.6× 58 0.5× 23 510
P Hentschke Sweden 15 604 1.4× 255 1.5× 23 0.1× 271 1.9× 109 0.9× 25 791
Katy Lambert United States 7 310 0.7× 122 0.7× 67 0.4× 21 0.1× 152 1.2× 9 545
C D Hillyer United States 8 333 0.8× 115 0.7× 22 0.1× 38 0.3× 89 0.7× 10 478
Jennie Treleaven United Kingdom 11 337 0.8× 89 0.5× 28 0.2× 64 0.4× 113 0.9× 20 564

Countries citing papers authored by M Bouvier

Since Specialization
Citations

This map shows the geographic impact of M Bouvier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Bouvier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Bouvier more than expected).

Fields of papers citing papers by M Bouvier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Bouvier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Bouvier. The network helps show where M Bouvier may publish in the future.

Co-authorship network of co-authors of M Bouvier

This figure shows the co-authorship network connecting the top 25 collaborators of M Bouvier. A scholar is included among the top collaborators of M Bouvier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Bouvier. M Bouvier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Krakow, Elizabeth F., Boglarka Gyurkocza, Barry E. Storer, et al.. (2019). Phase I/II multisite trial of optimally dosed clofarabine and low‐dose TBI for hematopoietic cell transplantation in acute myeloid leukemia. American Journal of Hematology. 95(1). 48–56. 7 indexed citations
3.
Green, Damian J., David G. Maloney, Barry E. Storer, et al.. (2017). Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma. Blood Advances. 1(24). 2247–2256. 17 indexed citations
4.
Kornblit, Brian, David G. Maloney, Rainer Storb, et al.. (2013). Fludarabine and 2-Gy TBI is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial. Biology of Blood and Marrow Transplantation. 19(9). 1340–1347. 22 indexed citations
5.
Rezvani, Andrew R., Ted Gooley, Mohamed L. Sorror, et al.. (2008). Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: a multicentre experience. British Journal of Haematology. 143(3). 395–403. 80 indexed citations
6.
Hockenbery, David M., Scott Cruickshank, Timothy C. Rodell, et al.. (2007). A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. Blood. 109(10). 4557–4563. 79 indexed citations
7.
Malone, Frances R., Wendy M. Leisenring, Barry E. Storer, et al.. (2007). Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant. Bone Marrow Transplantation. 40(8). 765–772. 28 indexed citations
8.
Qiu, Ruolun, Yao Assita, P. Vicini, et al.. (2004). Diminishing the risk of nonrelapse mortality in hematopoietic stem cell transplantation: Prediction of exposure to the cyclophosphamide metabolite carboxyethylphosphoramide mustard. Clinical Pharmacology & Therapeutics. 76(3). 270–280. 21 indexed citations
9.
McDonald, George B., M Bouvier, David M. Hockenbery, et al.. (1998). Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: A randomized, controlled trial. Gastroenterology. 115(1). 28–35. 55 indexed citations
10.
Oh, H, et al.. (1998). Plasma thrombopoietin levels in marrow transplant patients with veno-occlusive disease of the liver. Bone Marrow Transplantation. 22(7). 675–679. 10 indexed citations
11.
Bouvier, M, et al.. (1995). ORAL BECLOMETHASONE DIPROPIONATE FOR TREATMENT OF HUMAN INTESTINAL GRAFT-VERSUS-HOST DISEASE. Transplantation. 60(11). 1231–1238. 1 indexed citations
12.
Bouvier, M, et al.. (1995). ORAL BECLOMETHASONE DIPROPIONATE FOR TREATMENT OF HUMAN INTESTINAL GRAFT-VERSUS-HOST DISEASE. Transplantation. 60(11). 1231–1238. 24 indexed citations
13.
Bienvenu, Jacques, et al.. (1992). Serum IL-2 level in rheumatoid arthritis: correlation with joint destruction and disease progression.. PubMed. 2(4). 239–43. 21 indexed citations
14.
Noël, Esther, et al.. (1991). Focal myositis: A pseudotumoral form of polymyositis. Clinical Rheumatology. 10(3). 333–338. 10 indexed citations
15.
Bouvier, M, et al.. (1986). Nécrose linguale au cours de la maladie de Horton.. La Presse Médicale. 15(8). 399–399. 5 indexed citations
16.
Bouvier, M, et al.. (1984). [Ankylosing spondylarthritis. Pathogenesis of the destructive disco-vertebral lesions. 15 cases].. PubMed. 13(1). 15–8. 3 indexed citations
17.
Bouvier, M, et al.. (1982). [Multiple erosive discopathies associated with ankylosing spondylitis (author's transl)].. PubMed. 62(8-9). 463–6. 3 indexed citations
18.
Bouvier, M, et al.. (1980). [Pseudopottic and pseudodystrophic forms of spondylodiscites of ankylosing spondylitis. Four personal cases and 20 observations from the literature].. PubMed. 47(1). 21–9. 1 indexed citations
19.
Bouvier, M, et al.. (1978). [Clinical aspects of IgE myeloma. Apropos of a personal observation and review of the literature].. PubMed. 45(3). 185–92. 2 indexed citations
20.
Lejeune, E, et al.. (1971). [Circumscribed osteoporosis of the long bones in the course of Paget's disease].. PubMed. 51(8). 499–502. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026